rs45468101
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000257.4(MYH7):c.5284-45G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0127 in 1,614,246 control chromosomes in the GnomAD database, including 409 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.015 ( 43 hom., cov: 32)
Exomes 𝑓: 0.012 ( 366 hom. )
Consequence
MYH7
NM_000257.4 intron
NM_000257.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.20
Publications
2 publications found
Genes affected
MYH7 (HGNC:7577): (myosin heavy chain 7) Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing distal myopathy. [provided by RefSeq, May 2022]
MHRT (HGNC:51291): (myosin heavy chain associated RNA transcript) This gene encodes a spliced long non-coding RNA that may act as a cardioprotective agent in the heart. Based on a study of a similar gene in mouse, the encoded transcript may regulate chromatin remodeling by acting as a decoy to the BRG1 chromatin repressor complex thus preventing it from binding to its genomic targets. Blocking the actions of BRG1 could be crucial in protecting the heart from pathological hypertrophy. [provided by RefSeq, Dec 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 14-23415315-C-A is Benign according to our data. Variant chr14-23415315-C-A is described in ClinVar as Benign. ClinVar VariationId is 188643.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0698 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYH7 | ENST00000355349.4 | c.5284-45G>T | intron_variant | Intron 36 of 39 | 1 | NM_000257.4 | ENSP00000347507.3 | |||
| MYH7 | ENST00000713768.1 | c.5284-45G>T | intron_variant | Intron 36 of 40 | ENSP00000519070.1 | |||||
| MYH7 | ENST00000713769.1 | c.5284-45G>T | intron_variant | Intron 35 of 38 | ENSP00000519071.1 | |||||
| ENSG00000258444 | ENST00000557368.1 | n.-24C>A | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0147 AC: 2236AN: 152236Hom.: 36 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
2236
AN:
152236
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0218 AC: 5492AN: 251484 AF XY: 0.0217 show subpopulations
GnomAD2 exomes
AF:
AC:
5492
AN:
251484
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0125 AC: 18271AN: 1461892Hom.: 366 Cov.: 34 AF XY: 0.0132 AC XY: 9601AN XY: 727246 show subpopulations
GnomAD4 exome
AF:
AC:
18271
AN:
1461892
Hom.:
Cov.:
34
AF XY:
AC XY:
9601
AN XY:
727246
show subpopulations
African (AFR)
AF:
AC:
333
AN:
33480
American (AMR)
AF:
AC:
1551
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
AC:
875
AN:
26136
East Asian (EAS)
AF:
AC:
3251
AN:
39700
South Asian (SAS)
AF:
AC:
2718
AN:
86258
European-Finnish (FIN)
AF:
AC:
352
AN:
53418
Middle Eastern (MID)
AF:
AC:
345
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
7757
AN:
1112012
Other (OTH)
AF:
AC:
1089
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1425
2850
4275
5700
7125
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0148 AC: 2256AN: 152354Hom.: 43 Cov.: 32 AF XY: 0.0158 AC XY: 1177AN XY: 74504 show subpopulations
GnomAD4 genome
AF:
AC:
2256
AN:
152354
Hom.:
Cov.:
32
AF XY:
AC XY:
1177
AN XY:
74504
show subpopulations
African (AFR)
AF:
AC:
413
AN:
41588
American (AMR)
AF:
AC:
369
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
AC:
126
AN:
3472
East Asian (EAS)
AF:
AC:
393
AN:
5170
South Asian (SAS)
AF:
AC:
174
AN:
4828
European-Finnish (FIN)
AF:
AC:
72
AN:
10628
Middle Eastern (MID)
AF:
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
AC:
608
AN:
68038
Other (OTH)
AF:
AC:
81
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
105
211
316
422
527
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
30
60
90
120
150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.